Protara Therapeutics, Inc. (TARA)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

28

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
30-Aug-24 4:05 PM View:	28-Aug-24 Gift 0	Shefferman Jesse CEO and President Director		Protara Therapeutics, Inc. - TARA	3% 904.45K to 935.5K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 8:20 PM View:	12-Sep-24 Sale ($215.84K)	Opaleye Management Inc. 10% Owner		Protara Therapeutics, Inc. - TARA	(22%) 2.56M to 1.99M	0	0	--	--	Show Txns Hide Txns

23-Jan-24 4:05 PM View:	19-Jan-24 Payment of Exercise ($5.82K)	Zummo Jacqueline Chf Scientific Operations Off		Protara Therapeutics, Inc. - TARA	14% 91.47K to 104.3K	0	0	--	--	Show Txns Hide Txns

23-Jan-24 4:05 PM View:	19-Jan-24 Payment of Exercise ($5.50K)	Bandari Jathin Chief Medical Officer		Protara Therapeutics, Inc. - TARA	47% 38.46K to 56.7K	0	0	--	--	Show Txns Hide Txns

23-Jan-24 4:05 PM View:	19-Jan-24 Payment of Exercise ($1.73K)	Fry Hannah VP, Controller		Protara Therapeutics, Inc. - TARA	29% 23.06K to 29.84K	0	0	--	--	Show Txns Hide Txns

23-Jan-24 4:05 PM View:	19-Jan-24 Grant 0	Fabbio Patrick Chief Financial Officer		Protara Therapeutics, Inc. - TARA	100% 0 to 22.0K	0	0	--	--	Show Txns Hide Txns